The FDA has just announced that they plan to postpone their scheduled advisory committee meeting on Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years. They do not […]
Search Results for: COVID vaccine
Increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna) since April 2021, particularly in adolescents and young adults. These rates for ages 16-24 following a second dose are above what is expected. Myocarditis or pericarditis has now been verified in 226 people ages 30 and younger who have received an mRNA COVID-19 vaccine and Federal Health Officials are investigating reports of approximately 250 more cases.
Due to this increase, the Advisory Committee on Immunization Practices (ACIP) is scheduled to hold an emergency meeting on June 18, 2021 to discuss myocarditis cases and the American Academy of Pediatrics (AAP) plans to closely monitor meeting.
Lyme Test/Lyme Neuropathologies/Military: Lyme Myths/Tick Bite/CDC: COVID Vaccine/Hopkins: IDSA, Lyme-COVID/FDA Clears PhageBank/HHS WG ’20 Report/Lyme Boundaries/Longhorned Tick Spread/J&J Vaccine/Babesiosis Increase
As part of the LymeX public-private partnership between Health & Human Services (HHS) and the Cohen Foundation, HHS has published an RFI in the Federal Register, 2.11.21 that seeks information on the current state of the science and technology to accelerate “innovative solutions” for Lyme disease diagnosis.
The Journal of American Medical Association (JAMA), (Kelley, JD, et al.) published “Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines” on October 11, 2022. Researchers investigated the incidence of severe COVID illness following vaccination/booster with BNT162b2, mRNA-1273, and Ad26.COV2.S in adults receiving care at Veterans Health Administration(VHA) facilities. This study took place at VHA facilities across the US between July 1, 2021, and May 30, 2022, when Delta and Omicron variants of COVID predominated.
Ticks & Biowarfare Investigation Passes House/Last Chance to Register for LDA Conf. Before Price Increase/COVID Impacts on Lyme Reporting/Monoclonal Antibody COVID Treatment/LDA Doctor Referral Now Open/Valneva Lyme Vaccine
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment.
Findings of a recent study, Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence, show that Moderna’s COVID-19 vaccine appears to have a […]
New IDSA Guidelines/Failure to Commandeer Patient Chapter/#GivingTues/New Test for Lyme/CO Ticks/Updated COVID Protocol/Canine-Human Lyme Data/Next WG Meeting/LDA Thanks 51 Groups/DoD: Funds Lyme Vaccine
The Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) announced on November 30, 2020, new guidelines for prevention, diagnosis, and treatment of Lyme disease. Among the treatment recommendations, the guidelines recommend oral antibiotic therapy for most patients with Lyme disease.
Co-Chair: “Persistent Lyme Religious Belief”/Lyme $$$ Amendments/ Tick Biowarfare Investigation Passes House/WNBA Denies Lyme-Covid Exemption/LDA’s New Spanish LymeR Primer/Lyme Vaccine Phase 2 Results/Asian Longhorned Tick Increases
Persistent Infection a Religious Belief? Working Group Co-Chair Says – YES! At the meeting itself, Working Group Co-Chair, Dr. David Walker, and Member Eugene Shapiro made and seconded many motions to remove material from the proposed draft report including the two sets of guidelines, shared decision making, access to care, Lyme treatment trials, and cost of Lyme disease.
Aucott Makes Case for Chronic Lyme/2 Pandemics: Lyme & Covid-19/PA Radio: LDA Discusses Lyme & TBD/New Lyme Vaccine/Study on Deer Tick Questing/Contentious WG Meeting/Maloney: Reducing Lyme Burden
John Aucott, Director, Johns Hopkins Lyme Disease Research Center & Assoc. Prof. of Medicine, Johns Hopkins Univ., published a piece in The Conversation providing his insight on the controversial topic of chronic Lyme disease. In the article, Aucott outlines the existence of a population of patients – an estimated 10-20% – with persistent, lingering symptoms months to years after treatment.